Schedule 13G ownership disclosure

Mereo BioPharma Group plc

Ordinary Shares · CUSIP: G6014T100

Event date: 2026-09-30

Filing-level shares
26,889,300.00
Percent of class
3.4%
  • BANK OF AMERICA CORP /DE/

    Shares: 26,889,300.00 · Class: 3.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000070858-26-000531
Form type
SCHEDULE 13G/A
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
Oct 28, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub